Search

The incidence of non-surgical rejuvenation in facial aesthetic surgery

Non-surgical facial rejuvenation has increased exponentially in the last 20–30 years in a society which demands immediate results with minimal downtime. The overall UK market is estimated at £3.6 billion annually. The use of facial injectables increased by 7000% between...

Building sustainable global partnerships – the BFIRST perspective on future-proofing global plastic surgery

The British Foundation for International Surgery and Training (BFIRST) marks their 10-year anniversary this year as an organisation. As the international outreach arm of the British Association of Plastic, Reconstructive & Aesthetic Surgeons (BAPRAS), BFIRST focuses on supporting surgeons in...

Higher dose neurotoxins – what’s new?

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. How can we achieve longer lasting results with neurotoxins? With a new...

Anatomy of the ageing lip

With lip augmentation an ever popular option for those seeking more youthful looks it is vital that practitioners have a proper understanding of anatomy. In the first of our two-part special focus (see here for Part 2) on lips Dr...

Multidisciplinary approach to breast cancer conservation – therapeutic mammoplasty

Edinburgh-based plastic surgeon Ewa Majdak-Paredes provides us with a comprehensive review of therapeutic mammoplasty, a multidisciplinary approach to breast-conserving surgery with an emphasis on oncological safety and good aesthetic outcomes. Breast cancer Each year over 55,000 women in the UK...

Factors influencing a career choice in plastic surgery as a UK medical student

The medical school curriculum is increasingly focusing on the role of a general practitioner, which has resulted in medical students having reduced exposure to surgical specialties. There has been a longstanding concern that plastic surgery teaching and exposure in the...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

Burns care in India: unique and continuing challenges

The author interviews Dr Shobha Chamania, Chief of Choithram Hospital Burn Unit, to obtain an insight into the unique challenges burns care practitioners face in India. Choithram Hospital Burn Unit is an Interburns accredited training centre located in Indore City,...

Soft tissue augmentation – a review

The author explains how treating the face as a 3D structure is key to a good result with invasive or non-invasive procedures. History Rejuvenation of the face and trying to reverse the effects of ageing dates back centuries. Facial volume...